WHOCC
Postal address:
WHO Collaborating Centre for Drug Statistics Methodology
Norwegian Institute of Public Health
Postboks 222 Sk°yen
0213 Oslo
Norway

Visiting/delivery address:
Sandakerveien 24C
Bygg C
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

R RESPIRATORY SYSTEM

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.


R01 NASAL PREPARATIONS

R01A DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE

This group comprises preparations for local treatment in nasal congestion (e.g. sympathomimetics) or for prophylaxis and treatment of allergic rhinitis (e.g. corticosteroids, cromoglicate preparations). Most of the products are nasal drops, nasal sprays or nasal inhalants.

See also R01B - Nasal decongestants for systemic use, and R06 - Antihistamines for systemic use.

The DDDs are based on treatment of both nostrils.

R01B NASAL DECONGESTANTS FOR SYSTEMIC USE

This group comprises preparations for systemic use in vasomotoric or allergic rhinitis etc., excl. plain antihistamines (see R06).

Combinations with antihistamines are classified in this group.

The DDDs are based on the treatment of rhinitis.

Last updated: 2018-12-13